Advanced search
Publication Cover
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
Volume 48, 2022 - Issue 5
Submit an article Journal homepage
406
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Flumazenil partially reverses gamma-hydroxybutyrate (GHB)-induced coma: a case report

Shiao-Yu Chena Division of Clinical Toxicology and Occupational Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, TaiwanORCID Iconhttps://orcid.org/0000-0002-7898-3575View further author information
ORCID Icon,
Feng-Yuan Chua Division of Clinical Toxicology and Occupational Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;b Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCorrespondence[email protected]
View further author information
,
Chih-Yu Yanga Division of Clinical Toxicology and Occupational Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;b Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;c Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;d Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;e Center for Intelligent Drug Systems and Smart Bio-devices(IDSB), Hsinchu, Taiwan;f Stem Cell Research Center, National Yang Ming Chiao Tung University, Taipei, TaiwanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9899-3159View further author information
ORCID Icon &
Der-Cherng Tarngb Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;c Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;d Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;e Center for Intelligent Drug Systems and Smart Bio-devices(IDSB), Hsinchu, TaiwanView further author information
Pages 629-630 | Received 06 Mar 2022, Accepted 19 Jun 2022, Published online: 22 Jul 2022

References

  • Felmlee MA, Morse BL, Morris ME. γ-Hydroxybutyric acid: pharmacokinetics, pharmacodynamics, and toxicology. Aaps J. 2021;23:22. doi:10.1208/s12248-020-00543-z.
  • Busardo FP, Jones AW. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Neuropharmacol. 2015;13:47–70. doi:10.2174/1570159X13666141210215423.
  • Lee DC, Satz WA, Dougherty T, Greene T. An investigation of flumazenil to antagonize gamma-hydroxybutyrate intoxication in a murine model. J Med Toxicol. 2006;2:68–70. doi:10.1007/BF03161174.
  • McMahon LR, Coop A, France CP, Winger G, Woolverton WL. Evaluation of the reinforcing and discriminative stimulus effects of 1,4-butanediol and gamma-butyrolactone in rhesus monkeys. Eur J Pharmacol. 2003;466:113–20. doi:10.1016/S0014-2999(03)01486-9.
  • Koek W, Carter LP, Wu H, Coop A, France CP. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone. Behav Pharmacol. 2006;17:239–47. doi:10.1097/00008877-200605000-00005.
  • Schmidt-Mutter C, Pain L, Sandner G, Gobaille S, Maitre M. The anxiolytic effect of γ-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil. Eur J Pharmacol. 1998;342:21–27. doi:10.1016/S0014-2999(97)01503-3.
  • Ross TM, McIntyre Ross T. Gamma hydroxybutyrate overdose: two cases illustrate the unique aspects of this dangerous recreational drug. J Emerg Nurs. 1995;21:374–76. doi:10.1016/S0099-1767(05)80087-X.
  • Thomas G, Bonner S, Gascoigne A. Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): a case report. BMJ. 1997;314:35–36. doi:10.1136/bmj.314.7073.35.
  • Verive M, Herr L. 1228: flumazenil antagonizes coma and respiratory depression due to 1,4-butanediol ingestion. Crit Care Med. 2012;40:1–328. doi:10.1097/01.ccm.0000425440.99905.12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.